Variant recombinant dermatophagoides pteronyssinus type 1 allergen protein and its preparation method and application
11359191 · 2022-06-14
Assignee
Inventors
Cpc classification
C07K1/34
CHEMISTRY; METALLURGY
A61K39/00
HUMAN NECESSITIES
C07K1/20
CHEMISTRY; METALLURGY
C07K1/36
CHEMISTRY; METALLURGY
International classification
Abstract
A DNA sequence encoding Der p1 protein having a particular base sequence is codon-optimized for the Pichia pastoris expression system, which is conducive to expressing Der p1 in Pichia pastoris. After gene optimization and adding an activating element to increase the expression of Der p1 in molecular level, it was found that Der p1 is expressed at a higher level as compared with the prior art and has biological activity similar to the natural protein.
Claims
1. A DNA sequence encoding a proDer p1 protein, said DNA having the base sequence as shown in SEQ ID NO: 1.
2. The DNA sequence of claim 1, wherein the DNA sequence is comprised in a vector pAO815, pPIC9, pPIC9K, pPIC3.5, pPIC3.5K, pPICZα A, B, C or pGAPZα A, B, C.
3. A DNA sequence of claim 2, wherein the vector is comprised in Pichia pastoris strain SMD1168, GS115, KM71, X33 or KM71H.
4. The DNA sequence of claim 3, wherein there is a 242 bp interval between the DNA sequence encoding proDer p1 protein and ATG of AOX1 on Pichia pastoris; and the DNA sequence encoding the proDer p1 protein is preceded by a sequence encoding an alpha-factor signal peptide and Kozak sequence GCCACCATGG.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2) The sequence before optimization corresponds to the nucleotide sequence of the natural proDer p1 gene; the sequence after optimization corresponds to the nucleotide sequence of the recombinant proDer p1 gene of the present invention, that is, the codon-optimized sequence.
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10) Lane 1 represents 500 bp DNA ladder; lane 2 represents a PCR product of the recombinant proDer p1 gene containing XhoI and XbaI restriction sites at both ends.
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
(31)
(32)
(33)
(34)
(35)
DETAILED DESCRIPTION OF EMBODIMENTS
(36) The invention is further illustrated below in conjunction with specific examples. It should be understood that the examples referred to are merely illustrative of the invention and are not intended to limit the scope of the present invention.
Example 1
Codon Optimization of Recombinant proDer p1
(37) Based on the DNA sequence of proDer p1 disclosed in EMBL-EBI (ENA accession no. FM177224.1), as shown in SEQ ID No: 2, the inventors performed codon optimization of the gene to obtain the proDer p1 gene of the present invention of which the nucleotide sequence is as shown in SEQ ID No: 1 and the amino acid sequence is as shown in SEQ ID No: 3. Comparison of each parameter before and after codon optimization of the proDer p1 is as follows:
(38) 1. Codon Adaptation Index (CAI)
(39) As can be seen from
(40) 2. Optimal Codon Usage Frequency (POP)
(41) As can be seen from
(42) 3. GC Base Content (GC Curve)
(43) The ideal distribution region of GC content is 30%-70%, and any peak outside this region will affect transcription and translation efficiency to varying degrees. As can be seen from the comparison of the average GC base content distribution region plots of the proDer p1 gene in
Example 2
Construction of an Expression Plasmid Containing the proDer p1 Gene
(44) A sequence of XhoI restriction site was introduced at the 5′ end, and a sequence of XbaI restriction site was introduced at the 3′ end of the codon-optimized proDer p1, and then full gene synthesis was performed. The synthesized gene fragment was constructed into the pUC57 plasmid supplied by GenScript (Nanjing) Co., Ltd., thereby obtaining a plasmid for long-term preservation, denoted as pUC57-proDer p1 plasmid.
(45) PCR amplification was performed using the pUC57-proDer p1 plasmid as a template, and primers of following sequences:
(46) TABLE-US-00001 upstream primer (SEQ ID No: 5): M13 F: TGT AAA ACG ACG GCC AGT downstream primer (SEQ ID No: 6): M13 R: CAG GAA ACA GCT ATG AC
(47) The total volume of the reaction was 50 μL, in which 2.5 μL of each primer at a concentration of 10 μmol/L was added, 1 μL of dNTP at a concentration of 10 mmol/L was added, and 0.5 μL DNA polymerase being Q5 (#M0491L, purchased from New England BioLabs) at 2 U/μL was added. The reaction conditions were 98° C. for 5 seconds, 55° C. for 45 seconds, and 72° C. for 30 seconds. After 25 cycles, the product was analyzed by 1.0% agarose gel electrophoresis. The results showed that the product size was consistent with the expected size (1000 bp) (results as shown in
Example 3
Construction of a Pichia Pastoris Host Engineering Strain Containing a Recombinant proDer p1 Gene
(48) Formulation of YPDS solid medium: the medium was formulated according to the instructions of Easy SelectPichia Expression Kit, Invitrogen, comprising 10 g/L yeast extract, 20 g/L peptone, 20 g/L glucose, 15 g/L agarose, and 182 g/L sorbitol.
(49) 1. Construction of a Host Engineering Strain Containing Codon-Optimized proDer p1
(50) Electrocompetent cells were prepared according to the method of instructions of Easy SelectPichia Expression Kit, Invitrogen. The plasmid pPICZα-proDer p1 obtained in Example 2 was linearized with Sac I restriction endonuclease (#R0156S, purchased from New England Biolabs), and precipitated with ethanol. The linearized vector was electrotransformed into competent cells of Pichia pastoris X33. The cells were plated on YPDS solid media and cultured at 30° C. until the transformants grew.
Example 4
Inducible Expression and Identification of Engineering Strains Containing Codon-Optimized proDer p1 Gene
(51) Formulation of BMGY medium: the medium was formulated according to the instructions of Easy SelectPichia Expression Kit, Invitrogen, comprising 10 g/L yeast extract, 20 g/L peptone, 3 g/L K.sub.2HPO.sub.4, 11.8 g/L KH.sub.2PO.sub.4, 13.4 g/L YNB, 4×10.sup.−4 g/L biotin, and 10 g/L glycerin.
(52) Formulation of BMMY medium: the medium was formulated according to the instructions of Easy SelectPichia Expression Kit, Invitrogen, comprising 10 g/L yeast extract, 20 g/L peptone, 3 g/L K.sub.2HPO.sub.4, 11.8 g/L KH.sub.2PO.sub.4, 13.4 g/L YNB, 4×10.sup.−4 g/L biotin, and 5 mL/L methanol.
(53) 1. Methanol-Induced Expression of an Engineering Strain of Codon-Optimized proDer p1
(54) The host monoclonal engineering strain obtained in Example 3 was picked into a 5 mL BMGY medium and cultured in a 50 mL sterile centrifuge tube at 30° C. and 220 rpm until OD.sub.600 reaches 1.0-2.0. 1 mL of the culture was stored, and the remaining strain solution was resuspended and transferred to BMMY for induced expression at a small scale, and methanol was supplemented every 24 hours to a final concentration of 1%. One week later, the supernatant of the strain solution was collected by centrifugation, and analyzed by SDS-PAGE gel electrophoresis and Western blotting. Brightness of expressed product bands was observed.
Example 5
Purification of Recombinant Der p1 Protein
(55) The Der p1 constructed in this invention is obtained mainly by ion exchange and hydrophobic chromatography purification methods. HiTrap SP FF, HiTrap Q FF, and HiTrap Phenyl HP were selected as the chromatographic packings. The specific steps are as follows:
(56) 1. Pretreatment of the Fermentation Broth by Impurity Removal
(57) The fermentation broth of host engineering strain containing proDer p1 obtained according to Example 4 was centrifuged by centrifugation at a low temperature at 12000 rpm for 15 minutes to collect a supernatant, and the supernatant was dialyzed in a 5 KD dialysis bag against a 25 mM sodium acetate buffer at pH 4.5 for 48 h, and filtered through a 0.45 μm filter membrane to obtain a supernatant of the treated fermentation broth.
(58) 2. Cation Exchange Chromatography
(59) The treated fermentation broth of the previous step was loaded on a SPFF cation exchange chromatographic column, wherein the equilibration buffer was 50 mM NaAc at pH 4.5, the elution buffer was 50 mM NaAc and 1.0 M NaCl at pH 4.5, isocratic elution was performed at 12%, 25% and 100%, and the sample peaks were mainly concentrated at the 25% elution peak.
(60) 3. Anion Exchange Chromatography
(61) The Der p1 protein peak purified in the previous step was collected, and the sample was ultrafiltered with a 20 mM NaH.sub.2PO.sub.4 solution at pH 6.0, and loaded on a HiTrap Q FF chromatography packing. The equilibration buffer was 20 mM NaH.sub.2PO.sub.4 at pH 6.0, and the elution buffer was 20 mM NaH.sub.2PO.sub.4 and 1.0 M NaCl at pH 6.0. The flow-through peak of Der p1 was collected. The flow-through peak of Der p1 protein was as shown in
(62) 4. Hydrophobic Chromatography
(63) The flow-through peak of Der p1 from the anion chromatography was collected, and ammonium sulfate was added to a final concentration of 1.5 M. The fermentation broth supernatant treated as above was loaded on a Phenyl HP chromatographic column The equilibration buffer was 20 mM NaH.sub.2PO.sub.4 and 1.5 M (NH.sub.4).sub.2SO.sub.4 at pH 6.0; the elution buffer was 20 mM NaH.sub.2PO.sub.4 at pH 6.0, isocratic elution was performed at 25%, 50%, 70%, and 100%, and the Der p1 protein is mainly concentrated at the 75% elution peak.
Example 6
Analysis of Der p1 Protein Activity
(64) The purified Der p1 protein was dialyzed against a PBS buffer at pH 7.4, and the protein concentration was determined by a BCA protein concentration assay kit (Cat No: 23225, purchased from Pierce), and fold-diluted to 250 ng, 125 ng, 62.5 ng, 31.25 ng, and 15.625 ng. Using the dot immunoblotting method, the obtained solution was detected for the reactivity with sera of patients allergic to Dermatophagoides pteronyssinus by comparing with natural Der p2 as the control.
Example 7
Determination of Gene Copy Number of Recombinant proDer p1 Engineering Strain
(65) 1. Inoculation in X33 strain: the strains were cultured in YPD media for 24 h, the X33 genome was extracted by a genomic extraction kit (purchased from Tiangen Biotech (Beijing) Co., Ltd.), and GAP gene was amplified using the X33 genome as a template, and GAP-1 and GAP-2 as primers of which the sequences are as follows:
(66) TABLE-US-00002 upstream primer (SEQ ID No: 7) GAP-1: GGTATTAACGGTTTCGGACGTATTG downstream primer (SEQ ID No: 8) GAP-2: GATGTTGACAGGGTCTCTCTCTTGG
(67) The total volume of the reaction was 50 μL, in which 2.5 μL of each primer at a concentration of 10 μmol/L was added, 1 μL of dNTP at a concentration of 10 mmol/L was added, and 0.5 μL DNA polymerase being Taq DNA Polymerase (M0267S, purchased from New England BioLabs) at 2 U/μL was added. The reaction conditions were 94° C. for 10 minutes, 94° C. for 30 seconds, 55° C. for 30 seconds, 68° C. for 60 seconds, and 68° C. for 5 minutes. After 30 cycles, the product was analyzed by 1.0% agarose gel electrophoresis. The results showed that the product size was consistent with the expected size (400 bp) (results as shown in
(68) 2. The proDer p1 gene was amplified using the pPICZα-proDer p1 plasmid of Example 2 as a template, and 5′ AOX and 3′ AOX primers with the following sequences:
(69) TABLE-US-00003 upstream primer (SEQ ID No: 9): 5′ AOX: GACTGGTTCCAATTGACAAGC downstream primer (SEQ ID No: 12): 3′ AOX: GGCAAATGGCATTCTGACAT
(70) The total volume of the reaction was 50 μL, in which 2.5 μL of each primer at a concentration of 10 μmol/L was added, 1 μL of dNTP at a concentration of 10 mmol/L was added, and 0.5 μL DNA polymerase being Taq DNA Polymerase (#M0267S, purchased from New England BioLabs) at 2 U/μL was added. The reaction conditions were 94° C. for 10 minutes, 94° C. for 30 seconds, 49° C. for 30 seconds, and 68° C. for 60 seconds, and 68° C. for 5 minutes. After 30 cycles, the product was analyzed by 1.0% agarose gel electrophoresis. The results showed that the product size was consistent with the expected size (1500 bp) (results as shown in
(71) 3. Calculation of Gene Copy Number:
(72) The concentration (ng/μL) of the standard plasmid was determined by a nucleic acid microanalyzer (Nanodrop2000, ThermoFisher). Copy numbers of GAP and proDer p1 were calculated according to the following formula:
Copies/u=(6.02×10.sup.23)×(ng/μl×10.sup.−9)/(DNA length×660)
(73) 4. Processing Samples to be Tested
(74) The pPICZα-proDer p1-X33 engineering strain was inoculated in YPD liquid media at 30° C. overnight; and the genome was extracted the next day, and its concentration (ng/μL) and purity were determined by a nucleic acid quantitative microanalyzer.
(75) 5. Establishment of a Standard Curve
(76) The standard plasmids of T-GAP and T-proDer p1 with known copy numbers were gradiently diluted to 10.sup.8, 10.sup.7, 10.sup.6, 10.sup.5, 10.sup.4, and 10.sup.3 copies/μl, respectively. The fluorescent quantitative PCR were performed using GAP-1 and GAP-2, 5′ AOX and 3′ AOX as primers, respectively.
(77) 6. Determination of Copy Number of ProDer p1 Gene in Recombinant Strains
(78) The genome sample of extracted pPICZα-proDer p1-X33 was serially 10-fold-diluted to obtain four gradients of stock solution, 10.sup.−1, 10.sup.−2, and 10.sup.−3. Fluorescent quantitative PCR was performed using GAP-1 and GAP-2, 5′ AOX and 3′ AOX as primers, and each gradient was assayed three times.
(79) TABLE-US-00004 TABLE 1 Results of copy number of proDer p1 in the genome detected by real-time fluorescent quantitative PCR Average Ct value gene copy number (10.sup.N)Copy number of proDer p1 gene in Pichia pastoris genome Copy number of the proDer p1 gene/copy DNA GAP proDer p1 proDer p1 number of the concentration gene gene GAP gene gene GAP gene Stock 17.41 23.18 7.02 5.87 5.46 solution 10.sup.−1 20.29 24.32 6.11 5.59 5.31 10.sup.−2 23.63 24.35 5.10 5.41 5.22 10.sup.−3 28.23 24.39 3.82 5.28 4.98
Example 9
Analysis of the Acting Elements in the proDer p1 Genome
(80) There is no stable additional plasmid in Pichia pastoris, the expression vector is homologously recombined with the host chromosome, and the exogenous gene expression framework is fully integrated into the chromosome to realize the expression of the exogenous gene; the typical Pichia pastoris expression vector contains a regulatory sequence of alcohol oxidase gene, and contains the main structures comprising AOX promoter, multiple cloning site, transcription termination and polyA formation gene sequence (TT), screening markers and the like. The promoter is a cis-element for gene expression regulation and an important element for the genetically engineered expression vector. The important role of the promoter at the transcriptional level determines the gene expression level.
(81) The proDer p1 genome was extracted according to the method of Example 8, and the proDer p1 gene was amplified from the genome using 5′ AOX and 3′ AOX as primers according to the method in Step 2 of Example 8. The obtained samples were sent to GenScript (Nanjing) Co., Ltd. to detect the acting element before and after the proDer p1 gene which was inserted into the genome. The results of genome sequencing indicated that the proDer p1 gene expression framework was integrated into the chromosome of Pichia pastoris by a single cross-insertion, which enabled the proDer p1 gene to express the gene using the AOX promoter on the yeast chromosome, and thus the expression level was higher.
(82) Generally, the closer the first ATG of the exogenous coding sequence to the ATG of AOX1, the better the expression effect. In the gene construction, the inventors chose an enzyme cleavage site closest to the ATG of AOX1, and found that the proDer p1 gene was away from ATG of AOX1 only by 242 bp. In addition, the alpha-factor signal peptide and Kozak sequence GCCACCATGG (SEQ ID NO: 11) were added in front of proDer p1 gene, and the signal peptide and the sequence can greatly improve transcription and translation efficiency and increase expression efficiency of proDer p1 gene in eukaryotes.